An investigational medication is what is being studied to see if symptoms improve while taking it. It is not yet approved for general use by regulatory authorities. This study uses an investigational medication called Riliprubart. The investigational medicine is injected in a vein or under the skin, either at the …
This study investigates the effectiveness and safety of an investigational medication compared to a placebo in treating Systemic Lupus Erythematosus (SLE). Participants in this study will be adults aged 18 to 70 years who have active SLE.Participants will be randomly assigned to one of two study arms: one receiving the …
This study investigates the efficacy and safety of an investigational therapy compared to a placebo in adults aged 18 and older with moderately to severely active ulcerative colitis. Participants in this study have an eosinophilic phenotype, meaning they have higher levels of eosinophils, a type of white blood cell, in …
This study investigates the effects of an investigational medication compared to a daily oral dose of another treatment in adults with relapsing forms of multiple sclerosis (RMS). This study aims to measure the annualized relapse rate (ARR) in participants aged 18 to 55 who have been diagnosed with RMS.Participants will …
This study investigates the effects of an investigational medication in adults with non-responsive celiac disease (NRCD) who follow a gluten-free diet. This study aims to understand how the investigational medication affects intestinal damage caused by gluten exposure, as measured by the villous height to crypt depth ratio, and its impact …
This study investigates the effects of an investigational medication compared with a placebo in adults with high-risk asthma. This study involves adults aged 18 to 80 years who have asthma but are not eligible for biologic treatments.Participants will receive either the investigational medication or a placebo, which is an inactive …
This study investigates the efficacy and safety of an investigational medication in adults with moderate to severe Crohn's Disease (CD). This study compares different doses of the investigational medication with a placebo to determine its effectiveness in managing CD symptoms.Participants will undergo various study procedures, including a Double-Blind (DB) treatment …
This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis. The study aims to evaluate how different doses of the investigational medication can achieve clinical remission in participants.Participants will undergo various procedures, including a screening period and treatment periods. The study involves a …
This study investigates the effects of an investigational medication compared to a placebo in adults aged 18 and older with warm autoimmune hemolytic anemia (wAIHA). The study aims to assess the effectiveness and safety of the investigational medication in achieving a durable hemoglobin response, which is a measure of the …
